Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgen replacement therapy and prostate safety.

Alvaro Morales1

  • 1Department of Urology, Queen's University, Kingston General Hospital, Ont., Canada. moralesa@post.queensu.ca

European Urology
|June 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occupational History and Health Status Among Older Adults in Ecuador: Evidence from the SABE Survey.

International journal of environmental research and public health·2026
Same author

Cardiac Myxoma With Gamna-Gandy Bodies in a Nicaraguan Patient: Leveraging Advanced Imaging to Reduce Mortality Risk.

Cureus·2025
Same author

[Anaplastic Pancreatic Cancer Simulating Invasive Gastric GIST: Report of a Case with Exceptional Survival].

Revista medica de Chile·2025
Same author

Management of Surgical Aortic Valve Replacement Degeneration With Transcatheter Aortic Valve Implantation (TAVI in SAVR): Experience in Nicaragua.

Cureus·2025
Same author

Dynamics of Ischemia/Reperfusion Injury Markers During Normothermic Liver Machine Perfusion.

Transplantation direct·2024
Same author

Hemoglobinuria following reabsorbed hemoperitoneum.

Cirugia espanola·2024

Exogenous testosterone therapy is generally safe for the prostate in hypogonadal men. While it doesn't cause prostate cancer, testosterone can accelerate existing malignancy, necessitating further research.

Area of Science:

  • Endocrinology
  • Urology
  • Androgen Research

Background:

  • Exogenous testosterone therapy has evolved, shifting focus to its prostate effects.
  • Concerns regarding testosterone's safety have decreased, but prostate gland interactions require further study.
  • Hypogonadal men on androgen therapy exhibit normal prostate volumes compared to eugonadal men.

Purpose of the Study:

  • To evaluate the safety of androgen supplementation, particularly concerning prostate health.
  • To address existing concerns and elucidate the relationship between testosterone therapy and prostate cancer.
  • To propose recommendations for androgen replacement therapy and prostate safety.

Main Methods:

  • Review of existing literature and studies on androgen supplementation and prostate outcomes.

Related Experiment Videos

  • Analysis of data regarding prostate volume, PSA levels, and flow parameters in hypogonadal men receiving therapy.
  • Examination of the impact of testosterone administration on pre-existing prostate malignancies.

    • Main Results:

    • Androgen therapy normalizes prostate volume in hypogonadal men.
    • Testosterone therapy leads to modest PSA elevations and minor changes in flow parameters.
    • No evidence suggests testosterone causes prostate cancer, but it can enhance existing cancers.

    Conclusions:

    • Current evidence does not support a causal link between appropriate androgen treatment in hypogonadal men and prostate cancer.
    • Further extensive research and larger studies are required to fully understand the long-term prostate safety of androgen therapy.
    • Recommendations for androgen replacement therapy and prostate safety are proposed, considering various hormones like dehydrotestosterone and growth hormone.